BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5355621)

  • 1. [Effect of excipients and of conditions of storage on the preservation of drugs. II. Case of tablets of acetylsalicylic acid base].
    Delonca H; Puech A; Segura G; Youakim Y
    J Pharm Belg; 1969; 24(7):317-31. PubMed ID: 5355621
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of excipients and storage conditions on drug preservation. 3. Coated tablets with acetylsalicylic acid base].
    Delonca H; Puech A; Segura G; Joachim J
    J Pharm Belg; 1972; 27(1):40-9. PubMed ID: 5017454
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of excipients and storage conditions on the conservation of drugs. I. Case of tablets with an acetylsalicylic acid base].
    Delonca H; Puech A; Segura G; Youakim Y
    J Pharm Belg; 1969; 24(5):243-52. PubMed ID: 5401551
    [No Abstract]   [Full Text] [Related]  

  • 4. [Stability of acetylsalicylic acid base tablets in tropical environment].
    Delonca H; Thai TT; Galen ML; Laget JP
    Pharm Acta Helv; 1972; 47(3):199-208. PubMed ID: 5031926
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of excipients and storage conditions on drug preservation. IV. Suppositories with acetyl salicylic acid base].
    Delonca H; Puech A; Segura G; Joachim J
    J Pharm Belg; 1972; 27(1):50-6. PubMed ID: 5017455
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of the chemical stability of acetylsalicylic acid tablets during storage in pharmacies of Concepción, Chile].
    Mennickent S; Yates T; Vega M; Gloria Godoy C; Saelzer R
    Rev Med Chil; 2002 Apr; 130(4):409-15. PubMed ID: 12090106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Formulation of effervescent tablets containing acetylsalicylic acid. III. Investigation of the stability of the active principles of tablets].
    Dévay A; Kovács P; Rácz I
    Acta Pharm Hung; 1989 Jan; 59(1):11-5. PubMed ID: 2711837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stabilization of acetylsalicylic acid in solid drug form. I. Determination of experimental conditions in the examination of the stability of acetylsalicylic acid in solid drugs].
    Stozek T; Krówczyński L
    Acta Pol Pharm; 1973; 30(4):403-8. PubMed ID: 4762336
    [No Abstract]   [Full Text] [Related]  

  • 9. Physical properties and dissolution profiles of acetaminophen and acetylsalicyclic acid tablets made from sucrose-based vehicles.
    Elsabbagh HM; Ghanem AH; Elshaboury MH
    Pharmazie; 1981; 36(7):488-92. PubMed ID: 7280001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of adjuvants on the dissolution rate and stability of acetylsalicylic acid in tablets. II. Effect of lubrication agents].
    Cid E; Jaminet F
    J Pharm Belg; 1971; 26(4):360-8. PubMed ID: 5142947
    [No Abstract]   [Full Text] [Related]  

  • 11. [Stabilization of acetylsalicylic acid in solid drug form. IV. Effect of coating on the dissolving rate of acetylsalicylic acid in pure substance and in tablets].
    Stozek T; Krówczyński L
    Acta Pol Pharm; 1973; 30(6):597-604. PubMed ID: 4775909
    [No Abstract]   [Full Text] [Related]  

  • 12. [Stabilization of acetylsalicylic acid in solid drug form. II. Influence of coating technic and coating material on some properties of coated acetylsalicylic acid and tablets made thereof].
    Stozek T; Krówczyński L
    Acta Pol Pharm; 1973; 30(4):409-18. PubMed ID: 4762337
    [No Abstract]   [Full Text] [Related]  

  • 13. [Stabilization of acetylsalicylic acid in solid drug forms. 3. Effect of coating method and coating materials on the stability of the acetylsalicylic acid].
    Stozek T; Krówczyński L
    Acta Pol Pharm; 1973 Oct; 30(5):527-32. PubMed ID: 4764194
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of adjuvants on the dissolution rate and stability of acetylsalicylic acid in tablets. 3. Effect of surface-active agents].
    Cid E; Jaminet F
    J Pharm Belg; 1971; 26(4):369-74. PubMed ID: 5142948
    [No Abstract]   [Full Text] [Related]  

  • 15. Generalized regression neural networks in prediction of drug stability.
    Ibrić S; Jovanović M; Djurić Z; Parojcić J; Solomun L; Lucić B
    J Pharm Pharmacol; 2007 May; 59(5):745-50. PubMed ID: 17524242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of the stability of polymeric matrix tablets containing famotidine from the positron annihilation lifetime distributions of their physical mixtures.
    Szente V; Süvegh K; Marek T; Zelkó R
    J Pharm Biomed Anal; 2009 Apr; 49(3):711-4. PubMed ID: 19188038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factors influencing the binding power of excipients for direct compression].
    Delattre L; Jaminet F
    Pharm Acta Helv; 1974; 49(3-4):108-16. PubMed ID: 4438386
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dependence of pill decomposition and liberation of active substances on pill mass and other factors].
    Bogs U; Därr A
    Pharmazie; 1973 Feb; 28(2):112-5. PubMed ID: 4687559
    [No Abstract]   [Full Text] [Related]  

  • 19. [Validity tests of accelerated aging].
    Balâtre P; Bouché R; Henschel V; Jonas J; Kinget R; Marco A; Pochet M; Robert H; Roland M; Rombaux J; Evrard-Versluys J
    J Pharm Belg; 1972; 27(4):417-41. PubMed ID: 4681075
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.